Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthesia Effects on Neuronal Activity in DBS Surgery
NCT03283150Phase 4Terminated
- Sponsor
- University of Wisconsin–Madison
- Start
- Dec 2017
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of propofol, remifentanil, dexmedetomidine in Parkinson's disease (PD), essential tremor (ET), dystonia, sponsored by University of Wisconsin–Madison. Started Dec 2017; status: terminated.
02
Drugs
propofolremifentanildexmedetomidine
03
Conditions
Parkinson's disease (PD)essential tremor (ET)dystonia
Beyond the preview
Go deeper on NCT03283150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03283150.